Position in ZTS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$109,514
-$396,899 QoQ
Shares Held
1,524
-56.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,089
of 1,408 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Continuum Advisory, LLC holds $354,270 across 17 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (30.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
207 | $112,158 | |
| 2 | ZTS |
Zoetis Inc.
This page
|
1,524 | $109,514 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
418 | $70,449 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,668 | $16,680 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
491 | $16,635 | |
| 6 | HLN |
Haleon plc
|
1,035 | $9,656 | |
| 7 | VTRS |
Viatris Inc
|
554 | $8,797 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
105 | $3,801 |
All Filings in ZTS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $109,514 | 1,524 | Shares | Sole | 2026-08-06 | |
| 2025-09-30 | $506,413 | 3,461 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $611,168 | 3,919 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $672,924 | 4,087 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $681,862 | 4,185 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $812,976 | 4,161 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $712,856 | 4,112 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $668,379 | 3,950 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $660,202 | 3,345 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $552,212 | 3,174 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $554,516 | 3,220 | Shares | Sole | 2023-12-13 | |
| 2023-03-31 | $517,628 | 3,110 | Shares | Sole | 2023-12-13 | |
| 2022-12-31 | $461,779 | 3,151 | Shares | Sole | 2023-12-13 | |
| 2022-09-30 | $516,938 | 3,486 | Shares | Sole | 2023-12-13 | |
| 2022-06-30 | $717,125 | 4,172 | Shares | Sole | 2023-12-13 | |
| 2022-03-31 | $794,529 | 4,213 | Shares | Sole | 2023-12-13 | |
| 2021-12-31 | $890,953 | 3,651 | Shares | Sole | 2023-12-13 | |
| 2021-09-30 | $728,607 | 3,753 | Shares | Sole | 2023-12-13 | |
| 2021-06-30 | $667,914 | 3,584 | Shares | Sole | 2023-12-13 | |
| No filing history on record for this holder in this stock. | ||||||